Speaking during the Wall Street Journal Tech Health event on Wednesday, Johnson & Johnson Chairman and CEO Alex Gorsky said the company is working to ensure its vaccines can be used and deployed effectively.
“We’re working very hard, both at the federal level at the local level, to do everything we can to make sure that these vaccines can be used and deployed in the very best possible way,” Gorsky said.
He said that he was proud of the progress in vaccinating Americans.
“We still have work to do, there’s still education and there’s still information that needs to take place,” he said.
“It’s going to take more effort. I think we’re finding out now, the good news was we got a lot of vaccines out to meet this initial surge in demand and now making sure we get the very best possible deployment and allocation and the distribution system gets even more agile, more flexible, not only here in the United States, between states, but in fact around the world will be work that we need to continue to stay focused on in the weeks and months ahead.”
Gorsky's comments follow a statement the company released yesterday, saying it is working to extend the shelf-life of its Covid-19 vaccine, amid reports that doses may expire before they are used in the US.
“We continue to work with the U.S. government and health authorities to support the use of our vaccine, which continues to play an important role, including among those who wish to be fully vaccinated with one shot,” Johnson & Johnson told CNN in a statement Tuesday. “We also continue to conduct stability testing with the goal of extending the amount of time our COVID-19 vaccine can be stored before expiry.”
Ohio Gov. Mike DeWine said in a new release Tuesday that 200,000 doses of the state’s J&J vaccine are set to expire before the end of the month, and the state is unable to share the doses with other states or countries.
Of the 21.4 million J&J doses delivered in the US, about 11 million have been administered, according to data from the US Centers for Disease Control and Prevention. The J&J vaccine can currently be stored for up to three months at refrigerator temperatures.